ACAD — ACADIA PHARMACEUTICALS INC

Ownership history in Logos Global Management LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Logos Global Management LP reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.68% (2022 Q2)
Avg. % of fund
1.53%
First filed
2022 Q2
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 850,000 +200,000 +30.8% 1.37% $22.7M $26.71
2022 Q2 INITIATED 650,000 — — 1.68% $9.2M $14.09
% of Fund (quarterly)    ACAD price (monthly, adj. close)

Other funds also holding ACAD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 9.24% BAKER BROS. ADVISORS LP 3Y 7Y 6.71% Birchview Capital, LP 3Y 7Y 2.67% Nan Fung Group Holdings Ltd 3Y 2.46% Axecap Investments, LLC 2.25% Stonepine Capital Management, LLC 3Y 7Y 1.95% RTW INVESTMENTS, LP 3Y 7Y 1.91% BRAIDWELL LP 3Y 1.74% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.1% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.95%
← Back to Logos Global Management LP Holdings